by Elena Iemma | Dec 19, 2024 | Blog
Even more Fearless in 2025 2024 was a year of transformation and momentum for us—a real steppingstone to EpiVax 2.0. We are grateful to our new CEO, Rich-Henry Schabowsky, for creating a work environment where innovation moves...
by Elena Iemma | Nov 19, 2024 | Blog
Talking out loud to myself (and about 7000 friends) It’s the time of year for gratitude As we approach the season of gratitude, I would like to THANK YOU, our colleagues in the immunogenicity space, who are “Science Forward”....
by Elena Iemma | Oct 29, 2024 | Blog
October is Rocking! Off to Amsterdam and Stockholm EpiVax Sets the Standards for the Generic Drug Industry Ok . . . that’s an over-the-top headline! But read the press release! It reflects our excitement about our new contract with FDA and, the statement is...
by Elena Iemma | Sep 16, 2024 | Blog
September Falling Forward The Transition Suddenly, summer is over! No more long bike rides, afternoon sailing sessions, or dinners in the back yard. We have fall to look forward to and in New England, that means crisp days and colorful foliage. Fall also brings...
by Elena Iemma | Aug 18, 2024 | Blog
Immunogenicity Risk Assessment: In Silico, In Vitro, and What’s Next Don’t Miss This one! Put this one on your calendar: Scientific and Regulatory Considerations for Assessment of Immunogenicity Risk … The gang will all be...
